MedPage Today2h
Gene Therapy May Be a Game Changer for Transfusion-Dependent Thalassemia
The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
Launch Thalassemia Bharat Mukt Abhiyan, Thalassemia advocacy group urges Nadda
As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...
The two proteins involved in Alzheimer's disease affect brain circuits differently, study shows
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...
Science Daily1d
The two proteins involved in Alzheimer's disease affect brain circuits differently
A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
2minutemedicine.com2d
Beti-cel gene therapy achieves high rates of transfusion independence in severe β-thalassemia
There were no serious adverse events or treatment-related mortalities. Evidence Rating Level: 2 (Good) Study Rundown: Transfusion-dependent β-thalassemia (TDT) is a condition that results in iron ...